S
Sanjay Kaul
Researcher at Cedars-Sinai Medical Center
Publications - 222
Citations - 25862
Sanjay Kaul is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Randomized controlled trial & Myocardial infarction. The author has an hindex of 67, co-authored 215 publications receiving 22556 citations. Previous affiliations of Sanjay Kaul include University of California, Los Angeles & Baylor University Medical Center.
Papers
More filters
Journal ArticleDOI
Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium
Roxana Mehran,Sunil V. Rao,Deepak L. Bhatt,C. Michael Gibson,Adriano Caixeta,John W. Eikelboom,Sanjay Kaul,Stephen D. Wiviott,Venu Menon,Eugenia Nikolsky,Victor L. Serebruany,Marco Valgimigli,Pascal Vranckx,David P. Taggart,Joseph F. Sabik,Donald E. Cutlip,Mitchell W. Krucoff,E. Magnus Ohman,Philippe Gabriel Steg,Harvey D. White +19 more
TL;DR: Bleeding complications have been associated with an increased risk of subsequent adverse outcomes, including MI, stroke, stent thrombosis, and death, in patients with ACS and in those undergoing percutaneous coronary intervention (PCI) as well as in the long-term antithrombotic setting.
Journal ArticleDOI
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
Morteza Naghavi,Peter Libby,Erling Falk,S. Ward Casscells,S. Ward Casscells,Silvio H. Litovsky,Silvio H. Litovsky,John A. Rumberger,Juan J. Badimon,Christodoulos Stefanadis,Pedro R. Moreno,Gerard Pasterkamp,Zahi A. Fayad,Peter Stone,Sergio Waxman,Paolo Raggi,Mohammad Madjid,Mohammad Madjid,Alireza Zarrabi,Alireza Zarrabi,Allen P. Burke,Chun Yuan,Peter J. Fitzgerald,David S. Siscovick,Chris L. de Korte,Masanori Aikawa,K.E. Juhani Airaksinen,Gerd Assmann,Christoph R. Becker,James H. Chesebro,Andrew Farb,Zorina S. Galis,Christopher L. Jackson,Ik-Kyung Jang,Wolfgang Koenig,Robert A. Lodder,Keith L. March,Jasenka Demirovic,Mohamad Navab,Silvia G. Priori,Mark D. Rekhter,Raymond D. Bahr,Scott M. Grundy,Roxana Mehran,Antonio Colombo,Eric Boerwinkle,Christie M. Ballantyne,William Insull,Robert S. Schwartz,Robert A. Vogel,Patrick W. Serruys,Göran K. Hansson,David P. Faxon,Sanjay Kaul,Helmut Drexler,Philip Greenland,James E. Muller,Renu Virmani,Renu Virmani,Paul M. Ridker,Douglas P. Zipes,Prediman K. Shah,James T. Willerson,James T. Willerson +63 more
TL;DR: The term "vulnerable patient" may be more appropriate and is proposed now for the identification of subjects with high likelihood of developing cardiac events in the near future and a quantitative method for cumulative risk assessment of vulnerable patients needs to be developed.
Journal ArticleDOI
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer,S. D. Anker,J. Butler,G. Filippatos,S. J. Pocock,P. Carson,James L. Januzzi,S. Verma,H. Tsutsui,M. Brueckmann,W. Jamal,K. Kimura,J. Schnee,C. Zeller,D. Cotton,Edimar Alcides Bocchi,M. Böhm,Dong-Ju Choi,V. Chopra,E. Chuquiure,N. Giannetti,S. Janssens,J. Zhang,J. R. Gonzalez Juanatey,Sanjay Kaul,H. P. Brunner-La Rocca,Béla Merkely,Stephen J. Nicholls,Sergio V. Perrone,I. Pina,P. Ponikowski,N. Sattar,Michele Senni,M. F. Seronde,J. Spinar,Iain B. Squire,S. Taddei,Christoph Wanner,F. Zannad +38 more
TL;DR: Those in the empagliflozin group had a lower risk of cardiovascular death or hospitalization for heart failure than those in the placebo group, regardless of the presence or absence of diabetes.
Journal ArticleDOI
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
Deepak L. Bhatt,James M. Scheiman,Neena S. Abraham,Elliott M. Antman,Francis K.L. Chan,Curt D. Furberg,David A. Johnson,Kenneth W. Mahaffey,Eamonn Martin Quigley,Robert A. Harrington,Eric R. Bates,Charles R. Bridges,Mark J. Eisenberg,Victor A. Ferrari,Mark A. Hlatky,Sanjay Kaul,Jonathan R. Lindner,David J. Moliterno,Debabrata Mukherjee,Richard S. Schofield,Robert S. Rosenson,James H. Stein,Howard H. Weitz,Deborah J. Wesley +23 more
TL;DR: The American College of Cardiology Foundation (ACCF) Task Force on Clinical Expert Consensus Documents (ECDs) as mentioned in this paper developed by the ACCF and other cosponsors are intended to inform practitioners, payers, and other interested parties of the opinion of the ACC and document cosponsors concerning evolving areas of clinical practice and/or technologies that are widely available or new to the practice community.
ACCF/AHA Expert Consensus Document ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
Wilbert S. Aronow,Jerome L. Fleg,Carl J. Pepine,Nancy T. Artinian,George Bakris,Alan S. Brown,Keith C. Ferdinand,Mary Ann Forciea,William H. Frishman,Cheryl Jaigobin,John B. Kostis,Giuseppi Mancia,Suzanne Oparil,Eduardo Ortiz,Efrain Reisin,Michael W. Rich,Douglas D. Schocken,Michael A. Weber,Deborah J. Wesley,Robert A. Harrington,Eric R. Bates,Deepak L. Bhatt,Charles R. Bridges,Mark J. Eisenberg,Victor A. Ferrari,John D. Fisher,Timothy J. Gardner,Federico Gentile,Michael F. Gilson,Mark A. Hlatky,Alice K. Jacobs,Sanjay Kaul,David J. Moliterno,Debabrata Mukherjee,Robert Rosenson,James H. Stein,Howard H. Weitz +36 more
TL;DR: The reader should view the expert consensus document as the best attempt of the ACCF and document cosponsors to inform and guide clinical practice in areas where rigorous evidence may not yet be available or evidence to date is not widely applied to clinical practice.